UK Markets open in 4 hrs 40 mins
  • NIKKEI 225

    27,651.08
    -319.14 (-1.14%)
     
  • HANG SENG

    24,969.68
    -116.75 (-0.47%)
     
  • CRUDE OIL

    71.95
    +0.30 (+0.42%)
     
  • GOLD FUTURES

    1,801.10
    +1.30 (+0.07%)
     
  • DOW

    35,058.52
    -85.79 (-0.24%)
     
  • BTC-GBP

    28,912.37
    +2,045.50 (+7.61%)
     
  • CMC Crypto 200

    942.00
    +65.77 (+7.51%)
     
  • Nasdaq

    14,660.58
    -180.14 (-1.21%)
     
  • ^FTAS

    4,010.29
    -15.70 (-0.39%)
     

Global Over the Counter (OTC) Drugs Market Report 2021

·5-min read

Dublin, July 15, 2021 (GLOBE NEWSWIRE) -- The "Global Over the Counter (OTC) Drugs Market, By Product (Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements [VMS], Other), By Dosage Form, By Distribution Channel, By Region, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering.

The Global Over the Counter (OTC) Drugs Market exceeded USD 140 billion in 2019 and is expected to grow at a CAGR of around 8.23% during the forecast period.

The Global Over the Counter (OTC) Drugs Market is driven by rising health consciousness among the population across the globe. Moreover, buying OTC drugs is cost effective as they need no prescription, which is expected to positively impact the growth of the market during the forecast period.

The availability and affordability of these medicines has further increased the adoption rates of the OTC drugs in the market. Also, rapidly expanding healthcare and pharmaceuticals industries, is further expected to bolster the growth of the market over the next few years.

The Global Over the Counter (OTC) Drugs Market is segmented based on product, dosage form, distribution channel, company, and region. Based on product, the market can be categorized into cough, cold and flu products, analgesics, dermatology products, vitamins, mineral and supplements (VMS) and other.

Out of these, the cough, cold, and flu products segment dominated the market in terms of largest market share until 2019 and is expected to maintain its leading position the market during the forecast period as well. This can be ascribed to growing number of infections which is leading to the rise in the number of infectious diseases.

The market is further driven by the increasing efforts to licencing of OTC drugs for the treatment of cough, cold and flu. In addition to this, vitamins, mineral, and supplements (VMS) segment is expected to grow at a high pace in the next 5 years on account of the rising popularity of VMS products in developed countries because of the increasing diseased population.

Based on the dosage form, the market is segmented into tablets, capsules, ointments, liquids, and powders. Out of these, tablets segment dominates the market and is expected to maintain its position. Tablets are usually preferred by the doctors and patients as it is the most convenient oral dosage form.

Based on the distribution channel, the market can be segmented into retail pharmacies, hospital pharmacies, online pharmacy, and others. Out of these, retail pharmacies segment is the leading segment as, these are easily accessible. Furthermore, retail pharmacies have availability of a variety of drugs.

The companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnership, agreements, and new developments in order to expand their geographic reach and to increase their customer bases.

Major players operating in the Global Over the Counter (OTC) Drugs Market include

  • Johnson and Johnson

  • GlaxoSmithKline PLC (GSK Consumer Healthcare)

  • Perrigo Company PLC

  • Reckitt Benckiser Group PLC

  • Takeda Pharmaceutical Company Ltd

  • Roche Holding AG

  • The Procter & Gamble Company

  • Sanofi S.A

  • Gilead Sciences Inc.

  • Bayer Healthcare AG

  • AstraZeneca plc.

  • Alacer Corp.

  • Alcon Inc.

Years considered for this report:

  • Historical Years: 2015-2018

  • Base Year: 2019

  • Estimated Year: 2020

  • Forecast Period: 2021-2025

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Over the Counter (OTC) Drugs Market

4. Executive Summary

5. Voice of Customer

6. Global Over the Counter (OTC) Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements (VMS), Other)
6.2.2. By Dosage Form (Tablets, Capsules, Powders, Ointments, Liquids)
6.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Other)
6.2.4. By Company (2019)
6.2.5. By Region
6.3. Product Market Map

7. Asia-Pacific Over the Counter (OTC) Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Dosage Form
7.2.3. By Distribution Channel
7.2.4. By Country

8. Europe Over the Counter (OTC) Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Dosage Form
8.2.3. By Distribution Channel
8.2.4. By Country

9. North America Over the Counter (OTC) Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Dosage Form
9.2.3. By Distribution Channel
9.2.4. By Country

10. South America Over the Counter (OTC) Drugs Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Dosage Form
10.2.3. By Distribution Channel
10.2.4. By Country

11. Middle East and Africa Over the Counter (OTC) Drugs Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Dosage Form
11.2.3. By Distribution Channel
11.2.4. By Country

12. Market Dynamics
12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape
14.1. Competition Outlook
14.2. Company Profiles
14.3. Leading Players Profiled

For more information about this report visit https://www.researchandmarkets.com/r/f4ibvo


CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting